Portfolio company
CombinatoRx
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops synergistic combination medicines for healthcare providers and pharmaceutical partners to treat various diseases using a high-throughput screening platform.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Corus Pharmaceuticals
This company develops biopharmaceutical medicines to treat patients with HIV, viral hepatitis, cancer and inflammatory diseases.
Drug Discovery
This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.
Confluence Life Sciences
This biopharmaceutical company develops kinase inhibitors to treat inflammatory disorders and cancer for pharmaceutical and biotechnology industries.
Recursion Pharma
This company provides a technology platform for drug discovery and development to pharmaceutical partners and develops internal therapeutic candidates for patients with unmet medical needs.
Complix
This company develops protein therapeutics based on its alphabody technology to treat cancer, viral diseases and autoimmune conditions for the pharmaceutical industry.
Pharmacyclics
This company develops small-molecule medicines for patients with cancer and immune-mediated diseases.
SelectX Pharmaceuticals
This biopharmaceutical company develops small molecule antimicrobials and therapeutics for unmet medical needs using a genetic chemistry platform for patients with infectious diseases.
Ingenix
This company develops an artificial intelligence system that integrates biological data to support drug development decisions for pharmaceutical and biotechnology organisations.
